Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
목요일, 9월 03

bioAffinity Technologies Inc

BIAFNASDAQ
Trade with Public
Trade with Public
$9.75
3.1647.95%
가까이에: Sep 1, 5:00 PM EST
$12.87
6.2895.3%
프리마켓: 5:40 AM EST
개요뉴스실적 전망목표가재무심리지분 현황비교주식 보고서

bioAffinity Technologies Analyst Price Targets

Wall Street analyst price targets and consensus rating for bioAffinity Technologies (BIAF).

Price Target Range —

Analyst Consensus — 1 Analysts

1Hold
# Analysts1

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Apr 1, 2025Maxim GroupAnthony VendettiDowngradeBuy→Hold—
Jul 23, 2024Maxim GroupAnthony VendettiInitiateBuy$6

Analyst Ratings News

PRO
Maxim Group Downgrades bioAffinity Technologies to Hold

Maxim Group analyst Anthony Vendetti downgrades bioAffinity Technologies (NASDAQ:BIAF) from Buy to Hold.
Benzinga Newsdesk

US Stocks Likely To Open Mixed After Disappointing Q1 Performance: 'April Does Better After A Weak Q1,' Says Expert

U.S. stock futures were swinging between gains and losses on Tuesday after a mixed session on Monday. Futures of major benchmark indices were mixed in premarket trading. President Donald Trump‘s “Liberation Day”, the term he’s used for April 2nd, the day of incoming reciprocal tariffs, preceded a drop in stock prices.
Rishabh Mishra

PRO
Maxim Group Initiates Coverage On bioAffinity Technologies with Buy Rating, Announces Price Target of $6

Maxim Group analyst Anthony Vendetti initiates coverage on bioAffinity Technologies (NASDAQ:BIAF) with a Buy rating and announces Price Target of $6.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved